Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study
30. Januar 2018 08:35 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from a pilot study conducted for...
Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release
20. September 2017 08:37 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that it has filed an Abbreviated New Drug Application (ANDA) with...
Elite Announces New Development and License Agreement with SunGen Pharma LLC
12. Juli 2017 08:31 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 12, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Announces Development and License Agreement with SunGen Pharma LLC
29. August 2016 08:00 ET
|
Elite Pharmaceuticals, Inc.; SunGen Pharma, LLC
NORTHVALE, N.J., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information
09. August 2016 16:20 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
04. Mai 2016 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 04, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Davis S. Caskey to...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
05. Februar 2016 12:42 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
02. September 2015 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCQB:ELTP) a specialty pharmaceutical company which manufactures and sells niche generic products and is developing a...